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Studies of the Interaction of Yersinia enterocolitica strain WA with 
Reticuloendothelial Cells of Swiss-Webster Mice
Director: M.J, Nakamura
Facultative intracellular parasitism by Yersinia enterocolitica 
has been mentioned by various workers but remains unconfirmed. The 
V and W virulence antigens elaborated by this organism have unknown 
effects on the effectiveness of the host immune response. Antibody's 
possible role as mediator of the macrophageibacterium interaction 
during systemic yersiniosis has been described only for avirulent 
organisms; nothing is known about its effect when fully virulent 
organisms are used. This study was undertaken to learn more about 
these aspects of the host-parasit^ relationship during systemic yersiniosis
Extracellular association of VW organisms with RES cells was estab­
lished by several models; a) injection of bacteria into mouse peritoneal 
cavities b) in vitro infection of mouse peritoneal macrophages c) in 
situ perfusion of livers with organisms d) systemic infection in 
vivo. Only virulent bacteria exposed to immune serum were ingested.
Results of in vitro studies also indicated that opsonized VW bacteria 
evaded destruction within macrophages, and apparently multiplied during 
experimental infection. ^
The humoral immune response of mice to heat-killed VW Y . entero­
colitica ^train WA was not protective against intravenous challenge 
with a VW inoculum. Specific antibody had only opsonic activity, 
which resulted in unrestricted bacterial growth within RES_organs,
Ultrastructural studies confirmed that neither VW^ or VW organisms 
altered the sequence of events which occur within macrophages after 
phagocytosis. Phagolysosomes formed and organisms remained inside 
them during the time course of experiments. Organism^ without virulence 
antigens, though inactivated, appeared the same as VW organisms which 
survived within cells.
A model of the host-parasite interaction during systemic yersiniosis 
is proposed. In the e^rly stages of septicemia, transformation of the 
VW organism to the VW phenotype occurs. This results in extracellular 
proliferation of organisms with resultant abscesses in RES organs.
On this basis, similarities of LD^Q values for these phenotypic variants 
can be explained.
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+  —5. Survival of Ŷ. enterocolitica strain WA (VW , VW 
and TSM) in cultures of mouse peritoneal macrophages 
after treatment of inocula with immune mouse serum .... 33
6. X* enterocolitica strain WA (TSM) in PBS being phago- 
cytosed by cultured mouse peritoneal macrophages
5 minutes after infection. X 30,000 ....................  35
7. X* enterocolitica strain WA (VW ) in IMS being phago- 
cytosed en masse by cultured mouse peritoneal macro­
phages 5 minutes after infection. X 13,000 ............  35
8. Cultured mouse peritoneal macrophages 60 minutes after 
infection with Y. enterocolitica strain WA (VW ) in PBS.
X 20,000 ...................................................  37
9. Cultured mouse peritoneal macrophages 5 minute^ after 
infection with Y, enterocolitica strain WA (VW ) in IMS.
X 28,500 ...................................................  37
10. Antibody-coated Y . enterocolitica strain WA (VW ) 
within phagocytic vacuoles of normal mouse peritoneal 
macrophages 5 minutes after infection. X 9,500 ........ 39
11. Antibody-coated Y . enterocolitica strain WA (TSM) 
within phagocytic vacuoles of normal mouse peritoneal 
macrophages 5 minutes after infection. X 37,650 ...... 39
VI
LIST OF FIGURES
Figure Page
12. Antibody-coated IT. enterocolitica strain WA (Vw"*") 
within phagolysosomes 60 minutes after infection.
X 44,700 ............................................... 39
13. Antibody-coated enterocolitica strain WA (VW^)
60 minutes after infection. X 52,370 .............  39
14. Antibody-coated Y. enterocolitica strain WA (TSM) 
within phagolysosomes 5 minutes after infection.
X 39,500 ....    39
15. Survival of Y. enterocolitica strain WA (VW and 
VW ) in blood, livers and spleens of passively 
immunized mice and control mice after intravenous 
challenge .............................................  47
V l l
ABBREVIATIONS
0 
A
API
C
cc
CPU
cm
DTK
EMEM
EMEM-HS
EMEM-HSA
F-1
G
gm
HKWC
HS
IMS
ip
iv
1
LE 
LD50
M
rag
ml
rain
angstrom
Analytab Products Incorporated 
temperature Celsius 
cubic centimeter 
colony-forming unit 
centimeter
delayed—type hypersensitivity 
Eagle's minimal essential medium
Eagle's minimal essential medium with horse serum
Eagle's minimal essential medium with horse serum
and antibiotics
Fraction — 1 antigen
gravity
grams
heat-killed whole cells
horse serum
immune mouse serum
intraperitoneal
intravenous
liter
Luria broth
lethal dose
molar
milligram
milliliter
minute
viix
Iran
mM
MNNG
MOX
nm
NMS
OD
PBS
RES
rpm
SDOC
sec
SEM
SW-RML
TEM
TSA
TSB
TSM
U
ug
um
V
W
millimeter
millimolar
N-methyl-N*-nitro-N-nitrosoguanidine
magnesium - oxalate agar
nanometer
normal mouse serum
optical density
phosphate-buffered saline
reticuloendothelial system
revolutions per minute
0.5% sodium deoxycholate in PBS
second
scanning electron microscopy
Swiss-Webster / Rocky Mountain Laboratory
transmission electron microscopy
tryptic soy agar
tryptic soy broth
temperature-sensitive mutant
International Unit, U.S.P.
microgram
micrometer
V antigen
W antigen
IX
Chapter I 
INTRODUCTION
Yersinia enterocolitica is a minute. Gram-negative, pleomorphic, 
fermentative bacterium which has recently gained notoriety as a gastro­
intestinal pathogen of humans (117). Gilbert (55) discovered the 
organism in upstate New York in 1933, and Schleifstein and Coleman (115) 
described it as Bacterium enterocoliticum in 1939. European investigators, 
unaware of its discovery in the U.S., knew of the organism as Pasteurella 
pseudotuberculosis type jB, 2» pseudotuberculosis X, Bacterium X or 
Germe X  (25,59,92,117). Frederiksen (49) classified the organism In 
the genus Yersinia and proposed its present name.
Cellular pleomorphism is a hallmark of the species. Organisms
undergoing rapid growth are minute coccobacilli, while those dividing
slowly range from 1.0 um to 12 jiim in length. Stained cells form palisades
similar to Corynebacterium species (15). Spores and capsules are not
formed (3). Motility via peritrichous flagella is present at 25°C but
odisappears at 37 C (97). The organism is a psychrophile, and grows 
maximally at 37°C (1).
Although slow growth occurs cn Salmonella-Shigella and MacConkey 
agars at 37°C, these media remain the most reliable methods for primary 
isolation of this organism from clinical specimens. However, careful 
observation of cultures is mandatory (126). Colonies are 0.5 mm to 
1.0 mm in diameter after incubation at 37^C for 48 hours, and are detected 
by observation with a binocular dissection microscope set at low magni­
fication and with oblique illumination (125). Competition with other 
bacteria for nutrients is poor; incubation of specimens in saline
oor Rappaport broth at 4 C for 7 days has been used for its selective 
growth and enrichment before culture (105). Most laboratories omit 
the enrichment procedure, and specimens are cultured directly onto 
MacConkey or Salmonella-Shigella agars (59).
Nilehn (96) described 5 biotypes of this species, based on 
esculin hydrolysis, indole production, nitrate reduction, the Voges- 
Proskauer reaction, decarboxylation of ornithine and fermentation of 
sucrose, lactose, xylose, salicin, sorbose, trehalose and sorbitol. 
Biotypes 2 and 4 usually cause infection in humans.
Mollaret and Nicolle (93) showed that bacteriophages are liberated 
from clinical isolates of Y. enterocolitica. Nilehn (98) noted that 
10 phage liberation patterns existed. Types 9a, 9b and 10^ (no phage 
liberated) are typical of pathogenic strains.
Winblad (132) and Wauters (135) described 34 serotypes based on 
the "0" somatic antigen. Clinical isolates from the U.S. are serotype 
0:5 or 0:8, while elsewhere they are usually 0:3 or 0:9. On rare 
occassion, serotypes 0:13, 0:16 and 0:17 have been associated with 
disease in humans (16).
The symptoms of intestinal infection persist from one to three 
weeks after an abrupt onset (107). Patients usually present with acute 
abdominal pain in the lower right quadrant, headache, nausea, cramps 
and low grade fever. Stools are loose and contain small quantities of 
mucus and blood. Enteric infection is most common in children, where 
it mimics appendicitis but actually involves the terminus of the ileum. 
Needless appendectomies have been performed on such patients. Prompt 
diagnosis and therapy are essential to the child patients' recovery.
In older patients, terminal ileitis leads to mesenteric lymphadenitis, 
and in the immune compromised, to septicemia (2,34).
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Sequela usually occur more often in adult females (76). Aseptic 
arthritis most commonly affects weight-bearing joints for extended 
periods. Other sequela , rarely reported, include erythema nodosum, 
glomerulonephritis and Reiter's syndrome (8). Treatment with tetracycline 
or ampcillin usually results in rapid recovery (58,108).
Yersiniosis occurs most often during autumn and winter because 
the organism survives well in cold climates. Of 12 recorded epidemics,
10 occurred in cold weather, including one at a Montana ski resort (9, 
45,56,139). Human disease caused by this organism has occurred in 
temperate regions with few exceptions.
Enteric disease caused by this organism is transmitted by the 
fecal-oral route (124). Tainted water or foodstuffs, especially milk 
products, have been suspected sources of infection (12,77,78,94,114). 
Zoonosis is also a possibility, with swine, dogs and rodents the most 
prominent suspected reservoirs of infection during some outbreaks (5.31, 
71). Insect-borne transmission remains unproven, although the organism 
has been isolated from a flea (106).
Several determinants of pathogenicity have recently been described 
for Y. enterocolitica. Pai and Mors (104) reported that culture filtrates 
of clinical isolates possessed enterotoxin-like activity as measured by 
the Y-1 adrenal cell, suckling mouse and rabbit ileal loop assays. The 
toxin has been characterized as a heat-stable protein similar in activity 
to a toxin produced by enterotoxigenic Escherichia coli (112).
Une (128) has described the ability of pathogenic Y. enterocolitica 
to penetrate HeLa cells grown in culture. This unique characteristic has 
been proposed as a method of identifying pathogenic isolates from clinical 
or food specimens (82). However, association of this observation
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with invasiveness in vivo is not presently possible, since it occurs 
only at room temperature.
Carter e^ al. (30) have recently reported that under appropriate 
culture conditions IT. enterocolitica serotype 0:8 expresses two 
virulence antigens, V and W, associated with Ŷ . pestis and Ŷ. pseudo- 
tuberculosis (19,21), Lawton et al. (79) have reported that the V antigen 
is a protein with a molecular weight of 90,000 and W is a lipoprotein 
weighing 145,000 daltons, and composed of 38% lipid and 62% protein.
Both antigens are always expressed together in wild-type pathogenic 
yersiniae, and neither is precursor to the other. These are the only 
known virulence antigens held in common with other members of the genus (30).
Burrows et al. (20) have stated that the V and W antigens help 
pathogenic yersiniae avoid phagocytosis by macrophages. The function of 
these antigens remains uncertain, however, since other investigators 
have shown that these structures are responsible for intracellular 
survival of organisms within phagocytic cells (67). Studies of mutant 
Y. pestis have revealed that the F-1 antigen, a surface-associated protein, 
also prevents intracellular killing of the organism by macrophages, and 
may be more significant in this respect than V and W antigens (136).
The endotoxin produced by Y. enterocolitica is not as potent as those 
produced by other enteric Gram-negative bacilli (70). Carter ah. (26) 
showed that the for crude endotoxin by the intravenous route was
2,200 /Jg, the equivalent of an infection with 10^^ organisms. This was 
quite significant because mice were used in the study. Other reports of 
the endotoxins' weak pyrogenicity have also appeared (101). Ogata (102) 
has demonstrated that the endotoxin of this organism is weakly antigenic, 
and has suggested that it is minor determinant of pathogenicity.
5
Y. enterocolitica has been considered a facultative intracellular 
pathogen (31). Such organisms evade antimicrobial mechanisms present 
in serum by living within macrophages, which are incapable of destroying 
them. Spread of disease is mediated by movement of infected macrophages 
and monocytes throughout the body. Examples of similar pathogens include 
bacteria in the genera Brucella, Pasteurella, Salmonella, Listeria, Myco­
bacterium and Francisella (43,62,86,99,119,122,128).
The host response to this type of pathogen is chiefly due to the 
interactions between ciculating thymus-derived lymphocytes (T-cells) and 
macrophages. Circulating T-cells make initial contact with the invading 
organism and undergo a process of rapid division that culminates in a 
population of cells which secrete proteins known as lymphokines. Specific 
lymphokines attract regional monocytes and macrophages to the site of 
infection, and trigger an increase in their metabolic, secretory and 
phagocytic activity. This process is known as activation (72). Activated 
macrophages function as the effector cells in the immune response to 
facultative intracellular pathogens (100).
Several lines of evidence support this concept of cell-mediated 
immunity, which was first proposed by Mackaness in 1962 (83). Adoptive 
transfer of lymphocytes from spleens of immunized mice protect recipients 
against challenge with facultative intracellular organisms (50,123). 
Transfer of sensitized macrophages produces like results (6). In 
contrast, immune serum is ineffective in protection (80). The importance 
of T-cells in macrophage activation has been demonstrated through studies 
of the immune response of athymic nude mice to challenge with certain 
facultative intracellular organisms. Also, the immunosuppressive effect 
of anti-thymocyte serum on host susceptibility to facultative intracellular 
organisms has been reported, as have similar deleterious effects of anti-
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macrophage serum and other macrophage toxins (11,66). Lastly, host 
immunity to facultative intracellular organisms is often accompanied by 
a state of delayed-type hypersensitivity (DTK). Acquired cellular 
immunity and DTH are thought to have closely related mechanisms, however, 
the former is long-lasting and non-specific while the latter is neither 
(42).
Although cell-mediated host immune responses against facultative 
intracellular organisms are generally accepted as significant, the import­
ance of the humoral response is in dispute. Early reports on immunity 
to tuberculosis and listeriosis indicated that sera from immunized animals 
did not protect recipients against challenge with the homologous organisms 
(42,77). It was concluded that antibodies played little or no role in 
the destruction of the challenge organisms, and that humoral immunity 
was unimportant with regard to this type of pathogen.
Despite this, however, there existed several early reports that 
indicated a stronger role for humoral immunity. Fong (48) reported that 
antitubercular immunity was enhanced when immune serum was administered 
to mice sensitized to M. tuberculosis strain BCG. Elberg ejt al. (46)
showed that immune serum was required for destruction of virulent 
Brucella melitensis by immune macrophages.
The greatest controversy concerning the function of antibody in host 
defense against facultative intracellular organisms is found in studies 
of immunity to salmonellosis. Salmonella species have long been con­
sidered this type of parasite, and the host response was originally 
considered similar to those induced by L. monocytogenes and M. tuberculo— 
sis. Collins et al. (39) demonstrated that a cellular mechanism, not
a humoral one, protected animals against challenge infection. Others 
have reported that enriched populations of T-cells from sensitized mice
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conferred protection upon recipients, whereas transfer of immunity 
with immune serum was ineffective. Also, it was found that attenuated 
live vaccines provided limited protection to mice but killed vaccines, 
which are poor stimuli of cellular immune responses, provided none (40). 
Several researchers have described the involvement of macrophages in the 
immune response to pathogenic salmonellae (53,87).
Although pathogens within this genus remained classified as facul­
tative intracellular organisms, evidence of a protective humoral mech­
anism for salmonellosis soon appeared. Jenkin and Benacerraf (68) showed 
that destruction of typhimurium by immune mouse macrophages vitro was 
accelerated upon addition of immune serum to the system, Jenkin and 
Rowley (69) reported that good protection was obtained in vivo if 
sufficient quantities of immune serum were transferred to recipients.
Hsu et al. (65) established that cytophilic antibodies enhanced specific
attraction of immune macrophages to virulent S. typhimurium, and that 
bactericidal activity of the cells was increased. Venneman and Berry 
(129} used heat-killed salmonellae and immunogenic ribosomal preparations 
to induce formation of antibodies to S. typhimurium, and found that 
either preparation induced protective humoral immunity to challenge. 
Recently, Hochadel and Keller (63) showed that recipients of purified 
B-lymphocytes of mice immune to S. typhimurium survived longer than 
recipients of sensitized T-cells. Although the humoral response was not 
totally protective, the results indicated that antibody played an important 
role in immunity.
The immune response to infection with pathogenic yersiniae is well 
described. This is true of Y. pestis in particular. Burrows (22) has 
shown that immunity to Y. pestis is primarily cellular. Solid immunity
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is dependent upon phagocytosis of the agent by immune macrophages.
Serum antibodies to specific virulence factors, most notably the 
F-1 protein in the outer envelope, opsonize virulent plague bacilli 
and render them more susceptible to ingestion and destruction by 
RES cells. Immune serum generally provides little protection against 
disease, as is true of immunization with killed virulent organisms (110). 
Vaccination with viable attenuated organisms confers effective immunity 
upon laboratory animals (33). Oddly, immunization with purified F-1 
protein induces a protective immune response, but also causes allergic 
reactions in many recipients. Apparently, antibodies to F-1 antigen 
enable phagocytosis of pestis to proceed, and allow intracellular 
killing of the agent to occur, while anti-V and anti-W antibodies are 
of secondary importance.
The cellular and humoral immune responses to infection with 
Y. enterocolitica remain poorly described, and controversy continues 
over their relative importance in protection against reinfection.
In humans, the immune response is postulated to be strictly humoral. 
Antibody titers are detectable within 7 days after onset of symptoms, 
but remain low during acute illness. Titers rise rapidly when convalesc­
ence begins three weeks later, and remain elevated for 2 to 6 months 
afterward. Typical values during this time range from 1:512 to 1: 20480 
(4). Antibodies to epithelial cells and smooth muscle appear during 
this period, and coincide with reactive conditions such as arthritis, 
carditis and glomerulonephritis. Cell-mediated immunity is apparently 
absent because PMNs, not monocytes and macrophages, infiltrate tissues 
affected during the enteric syndrome. Also, lymphocytes are absent from 
lesions, or are few in number. This acute inflammatory reaction indicates
that the cellular portion of the immune system is not heavily involved 
in the host response to infection, and that the organism is apparently 
multiplying outside of RES cells while abscesses are formed.
The response of laboratory animals to experimental yersiniosis 
is dependent upon the animal used and the route of entry of the organism.
Use of different systems has led to contradictions concerning the 
roles which immune cells and antibodies play in the host's reaction to 
this pathogen. Zaremba (138) recently reported that Balb/C mice infected 
per os with Y. enterocolitica serotypes 0:3, 0:4 or 0:9 displayed a 
cellular immune response. Irradiated animals were more susceptible to 
infection, and macrophages taken from animals with an activated RES 
showed increased bactericidal activity Jn vitro, and displayed classical 
migration inhibition when incubated with sensitized, T-cell enriched 
populations and specific antigen. Granulomatous lesions, not abscesses, 
were reported as the dominant pathologic change in infected animals.
This suggests that a more chronic infectious process occurred, which, 
in turn, implicates facultative intracellular existence of the parasite 
within RES cells. Une (127) has also described a cell-mediated response 
of rabbits to enteric infection with serotype 0:3. Mononuclear phagocytes 
containing the challenge organism were located in Payer's patches and 
lamina propria of infected animals, and granulomas developed in infected 
livers and spleens.
Critics of these studies state that the model systems used do not 
duplicate the enteric infection in humans. Abscesses, not granulomas, 
occur during the human disease, and there is no apparent involvement of 
helper T-lymphocytes in a cell-mediated response. Alonso (7) has 
shown that nude mice and cyclophosphamide-treated outbred mice have the same
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susceptibility to enteric infection as do controls. Nude mice possess 
no functional T-lymphocytes, and cyclophosphamide suppresses cell- 
mediated immune responses to T-cell dependent antigens. Inability to 
mount a cellular response to infection, therefore, had no effect on 
host survival. Carter (27) described the first accurate animal model 
of human infection with Y. enterocolitica serotype 0:8, a strain found 
exclusively in the U.S.. Abscesses appeared in the Peyer's patches, 
livers, spleens and lungs of infected outbred mice during enteric 
disease. Protective humoral immunity was demonstrated by passive transfer 
of immune serum to normal recipients, which were then challenged with 
the homologous organism (29). Spleen lymphocytes from immune animals did 
not protect recipients against infection by the intravenous route.
However, since there were no in vitro correlate studies of T-cell sensiti­
zation during infection, it was unknown if a cell-mediated response 
did in fact occur. Despite some drawbacks, this system provided researchers 
with a very accurate model of human disease; however, results obtained 
were in conflict with those of others who had used the same species of 
animal, yet different strains of the organism.
Statement of Research Problem
Controversy exists regarding the host immune response to entero­
colitica during enteric disease. Various animal model systems have yielded 
conflicting data, particularly the mouse model. The function of this 
organisms' virulence antigens during interaction with the RES is unknown. 
Lastly, the possible role of antibody as mediator of RES-directed destruction 
of this organism during systemic infection has not been investigated.
This project was designed to further explore these aspects of the host-
hip.
Chapter II 
MATERIALS AND METHODS
Animals
Adult Swiss-Webster (SW-RML) mice between 4 and 8 weeks of age 
were obtained from the Rocky Mountain Laboratory, U.S. Public Health 
Service, Hamilton, Montana. All animals were maintained on standard 
lab chows and water ad libitum.
Organisms
Yersinia enterocolitica strain WA (serotype 0:8, biotype 4, phage 
type IOq ) was provided by Dr. P. B. Carter, Trudeau Institute, Incorporated, 
Saranac Lake, New York. The organism was maintained on tryptic soy agar 
slants (TSA, Difco, Detroit, MI) which were incubated at 23°C for 48 hours
and stored at 4°C. Its virulence was preserved by serial passage through
adult SW-RML mice. The LD^q , conducted over a 14-day period, was approxi­
mately 250 organisms (28,109).Virulent organisms were stored in 83% 
tryptic soy broth (TSB, Difco) and 15% glycerol at -70°C (28). Cultures 
were prepared by obtaining growth at 23°C to mid-exponential phase in TSB. 
Purity of culture was monitored with the API 20E system (Analytab Products, 
Inc., New York, NY) (111).
Viable Cell Count: Growth Curve
An 18-hour culture of Y. enterocolitica strain WA was incubated at 
23^C in LB broth (Appendix) and diluted 1:50 in 100 ml of LB broth. The 
subculture was incubated at 23°C on a rotating shaker at 100 rpm. After
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30 minutes, the optical density (OD) of the culture was measured at 
550 nm in a Coleman Junior II spectrophotometer. Readings were recorded 
at 30 minute intervals for 12 hours. Viable cell counts were determined 
by serial dilution of the culture in Dulbecco's phosphate-buffered 
saline (PBS) (Appendix). Appropriate dilutions were inoculated 
onto LB agar plates and incubated at 23^C for 48 hours. Colony count 
determinations were performed with a Quebec colony counter (New Brunswick 
Scientific Model C-101).
Nitrosoguanidine Mutagenesis : Survival Curve
N-methyl-N*-nitro-N-nitrosoguanidine (MNNG) is a mutagen which induces 
base substitutions primarily at the replication point of the bacterial 
genome C 91). Its main advantage is its ability to induce high mutation 
frequencies with little killing. Maximal mutation frequencies usually 
occur when 50% to 90% killing of the cell population is reached.
A survival curve was constructed to determine the amount of time 
necessary for 90% killing of a cell population by MNNG. An overnight 
culture of Y. enterocolitica strain WA in 50 ml of LB broth was subcultured 
to 6 culture tubes containing 5 ml each of LB broth. These were incubated
g
at 23°C until the cell density reached 10 colony-forming units (CPU) 
per ml (OD^^Q = 0.20). The cultures were then pooled in 15 ml conical 
centrifuge tubes and spun at 1000 rpm for 10 minutes. Pelleted cells were 
washed twice with 5 ml of citrate buffer (Appendix), Samples of 4 ml each 
were transferred to 8 culture tubes which were kept at 23^C in a water bath 
A 0.2 ml volume of a 1 mg/ml solution of MNNG in citrate buffer was then 
added to each tube at a final concentration of 50 ^ig/ml. At 0, 5, 10,
20, 30, 45, 60 and 90 minutes after exposure to MNNG, a treated culture
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was centrifuged and washed once with cold phosphate buffer, pH 7.0
(Appendix). Pelleted cells were resuspended in cold phosphate buffer
and were immediately diluted with cold PBS. Appropriate dilutions were
o
spread with bent glass rods on LB agar plates and incubated at 23 C for 
48 hohrs. Colony counts were determined and a semilgarithmic graph 
of cell survival as a function of exposure time was plotted.
Isolation of a Temperature-Sensitive Mutant
Temperature-sensitive mutations induced by MNNG are quite rare,
occurring in only 0.01% of the treated cell population (24). Cells were
exposed to MNNG for 90 min, after which they were prepared for plating.
Batches of 100 plates prepared after each treatment served as master plates
ofor replicas after incubation at 23 C for 48 hrs..
o oThe mutant, designated herein as TSM, would grow at 23 C but not 37 C,
the incubation temperature of cells cultures. LB agar plates, prewarmed
to the restrictive temperature (37 C), served as replicas of master plates
(81). Replica plates were incubated at 37 C for 48 hrs while the master
oplates were reincubated at 23 C. Colonies absent from the replica plates
were isolated for further characterization. Isolates were periodically
tested for temperature sensitivity. Gram-stained and identified as
o
_Y. enterocolitica with the API 20E system, used at 23 C, A growth curve 
of the TSM used in this study was determined as described for strain WA.
Vaccine Preparation
Overnight cultures of Ŷ . enterocolitica strain WA or TSM were diluted 
1:50 into a total of 1000 ml of TSB, which had been dispensed into flasks in
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o100 ml quantities. Subcultures were incubated at 23 C for 24 hours and
centrifuged at 1000 rpm in an lEC model UV centrifuge. Pelleted cells
were rinsed twice with 50 ml of sterile distilled water per 100 ml of
culture. Concentrated cells were placed in 15 ml conical centrifuge tubes
oand heated in a water bath for 1 hour at 56 C. Heat-killed whole cells
(HKWC) were then centrifuged in an IEC clinical centrifuge at 1000 rpm
for 30 minutes. Pelleted HKWC were resuspended with sterile distilled
water at a final concentration of 100 times the original culture and
otransferred to sterile serum bottles for storage at -20 C. The stock 
suspension was diluted with sterile PBS to a final concentration of 2 mg 
of HKWC per ml for mouse vaccination. Merthiolate was added to the vaccine 
preparations at a final concentration of 0.02% for preservation.
Adult female SW-RML mice were injected intravenously (iv) with 0.01 ml 
of vaccine (200 /ig/dose) at weekly intervals for 4 weeks. Blood from 
immunized mice was collected from the brachial artery. Sera were pooled 
after separation from whole blood and were clarified by centrifugation 
before storage at -20°C. Sera were heat-inactivated at 56°C for 1 hour 
to destroy complement activity before use in experiments.
Bacterial Agglutination Test
Tube agglutination titers of immune sera were measured by standard
laboratory procedures (83). A stock suspension of HKWC of Y. entero-
9colitica strain WA or TSM, containing approximately 10 cells per ml, was
used as the test antigen. Serum was diluted 1:10 in a 1 ml test tube by
addition of 0.05 ml serum to 0.45 ml sterile PBS. Eight serial two-fold
dilutions of serum were prepared and an equal volume of antigen was added
oto each tube. Tubes were sealed and Incubated overnight at 37 C. The
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agglutination titer was determined as the reciprocal of the highest 
serum dilution showing agglutination of the antigen.
Media
Powdered Eagle's minimal essential medium (Flow Laboratories, Santa 
Clara, CA) was reconstituted to 90% of its final volume with triple dis­
tilled water. The medium was adjusted to pH 7.2 with approximately 1.0
gm/ml of NaHCOg, sterilized by filtration through a 0.22 um filter (Seitz
oInc., New Yrok, NY) and stored at 4 C. Prior to use, sterile penicillin 
G and streptomycin sulfate (Sigma Chemical Co., St. Louis, MO) were added 
at final concentrations of 100 mg/ml and 100 ug/ml, respectively (EMEM-A). 
Sterile 1—glutamine (Sigma) was added at a final concentration of 0.292 
gm/1, and tricine buffer (N-tris-hydroxymethyl-methyl glycine. Sigma) was 
added at a concentration of 1.792 gm/1. Horse serum (Flow Laboratories) 
was heat-inactivated at 56°C for an hour and added at a final concentration 
of 4% (EMEM-HSA).
Cell Cultures
Mononuclear phagocytic cells aspirated from mouse peritoneal cavities 
were used for in vitro studies of the interaction between the mouse and 
Y. enterocolitica strain WA. No eliciting agents were used for cell collec­
tion since they alter cellular metabolism (90).
Adult male SW-RML mice were sacrificed by cervical dislocation, dipped 
in Amphyl disinfectant and pinned face upward on a mounting board. The 
abdominal skin was incised and reflected back, and 4 ml of EMEM-HSA with 
10 U/ml heparin was injected into the peritoneal cavity. After the abdomen 
was massaged with sterile forceps, the peritoneal sac was drained aseptically
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with a 5 cc syringe fitted with an 18 gauge needle. Aspirated fluid was
placed in cold, sterile, siliconized*glass centrifuge tubes. Bloody as-
priates were discarded. Fluids were centrifuged at 50 G for 5 min, and
the supernatant fluid was discarded. Cells were resuspended in 5 ml of
0.83% NH Cl, After incubation at room temperature for 20 min cells were 4
centrifuged, rinsed 3 times with sterile PBS and resuspended with EMEM-HSA
6at a final concentration of 10 cells/ml. Cells were dispensed onto 13 mm 
glass cover slips (Bellco, Vineland, NJ) in the wells of culture vessels 
(Linbro 24-well culture plates. Flow Laboratories) at a rate of 10^ cells 
per well and incubated in a humid chamber at 37°C with an atmosphere of 
95% air and 5% CO^. After 45 min, nonadherent cells were removed from the 
cultures by gentle rinses with sterile PBS and simultaneous aspiration. 
Cultures were maintained for 24 hrs with EMEM-HSA and then given EMEM-HS 
for J.2 hrs preceding experiments. This aided removal of antibiotics from 
the cultures.
Scanning Electron Microscopy
+  —Intracellular association of Ŷ . enterocolitica strain WA (VW , VW 
or TSM) with cultured mouse peritoneal macrophages was determined by obser­
vation of infected cells with a Zeiss Novascan electron microscope (SEM). 
Infected cell cultures on glass coverslips were fixed in 2% glutaraldehyde 
in Millonig's buffer, pH 7.15 (Appendix) for 1 hr, rinsed with Millonig's 
buffer and then rinsed with sterile distilled water, placed in a saturated 
solution of thiocarbohydrazide (Polysciences, Warrington, PA) for 15 min, 
and then rinsed again with distilled water and treated with 1% aqueous 
OsO^ for 1 hr.. After a final rinse with distilled water, the fixed cells 
were dehydrated rapidly through a series of graded ethanol solutions?
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rinsed twice with absolute ethanol and dried in a critical-point dryer 
(Tousimis Samdri, New York, NY) with CO^ as the carrier gas. A 250 8 
coating of palladium-gold (60:40 ratio) was applied to the fixed cells 
with a sputter apparatus (Structure Probe, Inc., West Chester, PA).
Coated specimens were mounted on aluminum mounting studs and examined.
Transmission Electron Microscopy
The intracellular interaction between Y_. enterocolitica strain WA 
+  —(VW , VW or TSM) and cultured mouse peritoneal macrophages was examined 
by transmission electron microscopy (TEM). Mouse peritoneal macrophages 
were cultured in vitro for 24 hrs, rinsed vigorously with sterile PBS and 
given fresh medium without antibiotics before experiments. At certain 
time intervals after infection with bacteria suspended in PBS, NMS or IMS, 
cultures were fixed in 2% glutaraldehyde in Millonig's buffer and left 
overnight at 4 C. They were then rinsed with cold Millonig's buffer and 
post-fixed for 1 hr in cold 1% OsO^ in Millonig's buffer. After a second 
rinse with cold Millonig's buffer, fixed cultures were dehydrated by pass­
age through a series of cold, graded ethanol solutions. The coverslips 
were then immersed in cold absolute ethanol which then rose to room tempera­
ture. Cultures were infiltrated with a 50:50 mixture of absolute ethanol 
and Spurr's embedding medium for 1 hr before transfer to undiluted Spurt's 
medium for 1 hour. Coverslips were then placed cell-side downward in 
plastic embedding molds filled with Spurr's medium and cured at 65°C for 
18 hours. Coverslips were detached from the cell monolayers by alternate 
immersion of the blocks in liquid air and distilled water at 23^C. Sections 
of the blocks were mounted with methacrylate glue onto hardened sectioning
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blocks, sectioned eri face with glass knives on a Sorvall Model 10 ultra- 
microtome and stained with a Zeiss EM 9S2 electron microscope.
In vivo Association of Y. enterocolitica strain WA with Mouse 
Peritoneal Phagocytic Cells
+ —Possible association of Y. enterocolitica strain WA (VW or VW )
with mouse peritoneal phagocytic cells was determined by a variation of
the method described by Taplits and Myrvik (121). Cultures grown overnight
in TSB at 23^C were cultivated in Higuchi’s medium (Appendix) (60) at 37°C
for optimal production of V and W virulence antigens, which may aid in
resistance to phagocytosis or intracellular killing by macrophages. Cells
ocultured in TSB at 23 C had the capacity to produce these antigens but 
were VW .
8When the cultures reached a density of 10 CFU/ml, they were centri­
fuged. Cells were rinsed 3 times with sterile PBS and were resuspended 
in sterile PBS, NMS or IMS to a final concentration of 10^ CFU/ml. Mice 
in groups of 6 were injected intraperitoneally (ip) with 1 ml of these 
suspensions. At 0, 60 and 120 min after injection, 2 animals from each 
group were sacrificed and the peritoneal cavities were filled with 5 ml 
of cold PBS which contained 10 U/ml heparin. Aspirated fluids were pooled 
within each group, placed in siliconized conical centrifuge tubes and 
centrifuged at 50 G for 5 minutes. This allowed separation of extracellu­
lar bacteria from peritoneal cells and cell-associated organisms. Super­
natant fluids were diluted with PBS and appropriate dilutions were inocu­
lated onto TSA plates for enumeration of extracellular bacteria. Cell- 
associated bacteria were released unharmed from pelleted cells with 0.5%
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sodium deoxycholate in PBS (SDOC) (65) for 5 min at room temperature. 
Bacteria freed from the cells were diluted with sterile PBS and inoculated 
onto TSA plates. Smears of aspirated cells were fixed in absolute 
methanol, stained with May-Grunwald Giemsa stain (Appendix) and examined 
for cell-associated bacteria.
Liver Perfusion Assay
This assay was used to study the interaction between antibody- 
coated Y. enterocolitica^ strain WA (VW or VW ) and an isolated organ 
of the reticuloendothelial system (RES). Mice were sacrificed by cervical 
dislocation, dipped in Amphyl disinfectant and pinned face upward on a 
mounting board. Skin was reflected back from the abdomen and thorax 
and an incision was made from the lower abdomen to the heart. The 
frontal portion of the rib cage was removed for easy access to the heart, 
and the abdominal musculature was reflected away from the body. Ligatures 
(white cotton thread) were placed around the hepatic portal vein, the 
inferior vena cava above the right renal vein, and the superior vena cava 
at a point 1 cm below the right atrium. The hepatic portal vein was held 
taut with sterile forceps as a 25 gauge needle attached to a 5 cc syringe 
of PBS was inserted 1 cm distal to the hepatic tree. The ligatures around 
the vein were secured and the connection was pressure tested. The inferior 
vena cava was then ligated. A 20 gauge needle was attached to a section of 
plastic tubing (inner diameter = 0 . 1  cm) and was inserted into the superior 
vena cava by way of the right atrium and secured by ligatures. Perfusion 
of the liver with sterile PBS began immediately afterward. Blood was 
rinsed from the livers within 5 min after the animals had been sacrificed.
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When the effluent fluid from the livers ran clear, PBS was quickly
+ —replaced by a suspension of VW or VW IT. enterocolitica strain WA in
PBS, NMS or IMS, Livers were perfused with 1 ml of a suspension, an average 
8of 10 CFU per organ. Livers were then rinsed with 5 ml of PBS. Fluids 
were perfused slowly through the livers at a rate of 0.1 ml/min to prevent 
formation of air bubbles or swelling of the organs. The entire procedure 
was usually completed within 1 hour. Upon completion of perfusions, livers 
were quickly excised from the mice and were homogenized individually in 
glass tissue grinders with teflon pestles (A. Thomas Co. Model 1902, 
Philadelphia, PA) which were immersed in ice baths to prevent heat damage 
to the specimens. Homogenates and effluent fluids were diluted with PBS 
and inoculated onto TSA plates for viability count determinations.
In each experiment, silica—treated livers served as controls for 
liver trapping activity not associated with RES cells. Animals were 
injected iv over a two day period with a total of 20 mg of fraction III 
Min-U-Sil silica (Whittaker, Clark and Daniels, New York, NY) prepared by 
the method of Larson (11). Livers were used in experiments 24 hours 
after treatment.
4- ”In vitro Interaction Between Y. enterocolitica strain WA (VW , VW or TSM) 
and Mouse Peritoneal Macrophages
This system was used to examine whether V and W antigens of IT. entero­
colitica strain WA inhibit phagocytosis or intracellular killing by mouse 
peritoneal macrophages and to define the role of antibody in this host- 
parasite interaction. Y . enterocolitica TSM was used to establish a 
baseline of macrophage bactericidal activity against avirulent (VW ) cells. 
Its survival without growth at 37^C permitted the study of cell-associated
21
bactericidal activity without concommitant bacterial multiplication,
a problem encountered in similar research by others (51).
Cells grown overnight in TSB at 23^C were cultivated at 37°C to mid-
+ —exponential phase in Higuchi's medium or TSB for growth of VW or VW bac­
teria, respectively. Cells were centrifuged and rinsed 3 times with PBS, 
and then resuspended with PBS, NMS or IMS and added to macrophage cultures 
at aratio of 10 bacteria per macrophage. Cultures were thoroughly rinsed 
with PBS at 30 min intervals during experiments to remove extracellular 
bacteria and prevent repeated phagocytosis of organisms. At 5, 10, 15, 30, 
45 and 60 min after infection, coverslips with adherent cells were pre­
pared for microscopic examination by fixation in absolute methanol for 
1 min followed by staining with May-Grunwald Giemsa stain, Coverslips 
were mounted on glass slides and examined at 1000 X magnification through 
a Zeiss Model K-18 microscope. The percentage of infected macrophages 
was calculated by observing a minimum of 200 macrophages per coverslip.
Viability of bacteria in macrophages was assessed by separate quanti­
fication of cell-associated and extracellular organisms. Cultures were 
rinsed with PBS, which was then combined with the culture medium of in­
fected cells for quantification of extracellular bacteria. Coverslips
with cell layers were removed from culture vessels and treated with 0.5% 
oSDOC at 23 C for 5 minutes. Bacteria released from the cells were then
4- —inoculated onto TSA for viable cell counts. Retention of the VW or VW
phenotype of the inocula was then confirmed by inoculating organisms onto
a solid medium deficient in Câ "*" and Mg cations, known as MOX agar (60),
owhich was selective for avirulent cells at 37 C. Lack of growth indicated 
a fully virulent cell population. Control counts were performed using TSA 
with 20 mM CaCl^ and 2,0 mM MgCl^*
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Passive Transfer of Sera
Antibody-mediated protection of mice against systemic infection 
4- —with VW or VW Y. enterocolitica strain WA was assessed by survival 
of recipients of IMS after challenge. Groups of 5 mice were injected iv 
with 10-fold dilutions of the organism 1 hr after administration of PBS,
MMS or IMS. Deaths of animals were recorded daily for 14 days and the
was calculated for each group.
The functions of antibody in vivo during various stages of infection
were also studied. Groups of 3 mice were injected iv with 1 ml of PBS or
6 +IMS and challenged 1 hr later with 10 CFU of VW or VW IT. enterocolitica 
strain WA. At 5, 10, 20, 30, 45 and 60 min after challenge, blood, liver 
and spleen specimens were collected from each group and pooled separately 
for quantification of viable organisms. Blood was diluted with PBS and
inoculated onto TSA plates. Homogenates of livers and spleens were com­
bined and diluted with sterile PBS before inoculation onto TSA plates.
Complement-Mediated Bacteriolysis Assay
+ -Lysis of VW and VW Y. enterocolitica strain WA and TSM by complement 
was studied by the method of Carter et al. (29). Bacteria were cultivated
in appropriate media at the proper temperatures to mid-exponential phase 
and were centrifuged and rinsed with sterile PBS. Cells were then resus­
pended with sterile PBS, MMS or IMS to a final concentration of 10^ CFU/ml.
oSuspensions which contained IMS were heated at 37 C for 1 hr to allow adher­
ence of antibody to the cells. All suspensions were then mixed with a
vortex apparatus (VWR Scientific Model 32) and diluted 2-fold with fresh
oguinea pig serum, a potent source of complement, and reincubated at 37 C.
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At 0, 5, 10, 15, 30, 45, 60, 90 and 120 minutes after addition of 
complement, suspensions were diluted with PBS and inoculated onto 
TSA plates for viable cell count determination.
Chapter III
RESULTS
Viable Cell Count : Growth Curve
Correlation of viable cell counts with optical density of cell 
cultures was accomplished by determining the growth curves of Y. entero- 
colitica strain WA at 23^C and 37°C in TSB and Higuchi’s media, res­
pectively (Figs. 1 and 2). At 23°C, plasmid-encoded genes for two
virulence factors, the V and W antigens, are retained but not expressed
24-  24-by this organism. When critical concentrations of Ca and Mg are
opresent in the culture medium at 37 C, these antigens appear on the
outer surface of the cell (61). MOX agar, which lacks these cations,
4-does not support growth of VW Y. enterocolitica, and was used for detection 
of V and W antigen production in cultures prepared for growth curves and 
for infection of animals or cell cultures. The organism displayed
flocculant growth in Higuchi’s medium during late exponential phase.
This characteristic is common among virulent strains of the genus when 
V and W antigens are produced (75).
Nitrosoguanidine Mutagenesis: Survival Curve
oSurvival of Y. enterocolitica strain WA in MNNG at 23 C was determined 
(Fig. 3). Since temperature-sensitive mutants occur only after cells 
have been extensively mutated, the treatment with MNNG was prolonged. A 
mutant with non-lethal changes in its genome was isolated after 90 min 
of treatment, when 97% of the cells had been killed by the mutagen.
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Fig. 1. Growth curve of Y. enterocolitica strain WA (VW ) in TSB 
at 23^C showing optical density readings COD = 550 nm) and viable 
cells per milliliter for various incubation periods. Optical density 
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Characterization of the Mutant
oThe mutant required for in vitro studies had to grow at 23 C
and survive but not multiply at 37^C, the incubation temperature of the
macrophage culture system. The organism would not possess V and W antigens
as it grew, because these are only produced at 37°C. The TSM isolated
for this project was, therefore, ideal for studying the destruction of
avirulent Y. enterocolitica by mouse macrophages, since problems posed by
extracellular bacterial growth were eliminated. Also, the extent of
cell-associated killing of bacteria could be determined more accurately.
The TSM selected for use was a stable mutant (data not shown). It grew
oin various media at 23 C, and also grew at this temperature after incu-
o obation at 37 C. Cell death at 37 C was negligible. Biochemical character­
istics measured by the API 20E identification system were the same as for 
wild-type Y. enterocolitica strain WA when the strip was incubated at 23°C. 
A growth curve of the TSM is shown in Fig. 4.
Complement-Mediated Bacteriolysis Assay
+  —Susceptibility of Y. enterocolitica strain WA (VW , VW and TSM)
to complement-mediated bacteriolysis was examined (Table 1). All resisted
olysis during incubation for 1 hour at 37 C in a mixture of high titer
IMS and fresh guinea pig serum, a potent source of complement. The
+ —TSM remained viable and displayed no growth, while the VW and VW organisms 
grew in the preparation.
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Table 1. Bactericidal activity of guinea pig complement against 
antibody-coated Y. enterocolitica strain WA (VW^, VW” and TSM),^
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Inoculum Time (min)
Number of Surviving Bacteria 
PBS NMS + C  IMS~+ C*
VW 0
5
10
15
30
45
60
90
120
2 .1'
1.7 
2.0
2.5 
2.2 
1.9
2.6 
2.2
1.8
2.4 
2.0 
1.9 
2.6
3.5 
4.4 
5.7
6.6 
8.0
2.2
2.6
2.9
3.1
3.8
4.$5.9 
6.8 
7.5
VW 0
5
10
15
30
45
60
90
120
1.8
2.2
2.0
1.6
1.9
2.1
2.4
2.7
2.7 
3.9
4.8 
5.3 
6.2 
7.1
1.7
2.0
2.6
3.4
4.2
5.1
6.2 
7.0 
7.9
TSM 0
5
10
15
30
45
60
90
120
1.2
0.9
1.5 
0.8 
1.0 
1 . 1  
1.7 
1.3
1.6
1.3
1.0
1.5 
0.9 
1.2 
0.7 
0.9 
1.1
1.5
1.0
1.3 
0.8 
1.1 
1.2 
1.0
1.4 
0.8 
1.8
inoculum of 10 CFU, incubated at 37°C.
multiples of 10 CFU.
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+ —
In vitro Interaction Between Y. enterocolitica strain WA (VW , VW 
or TSM) and Cultured Mouse Peritoneal Phagocytic Cells
In vitro experiments indicate that V and W antigens of this
organism may serve an antiphagocytic function (Table 2). Virulent
bacteria suspended in PBS or NMS did not associate with phagocytic cells.
This was confirmed by light microscopic examination of cultures
+(data not shown). VW organisms were found in association with macrophages
only after addition of IMS to the system. Decreased viability of the
inoculum did not occur. Hence, V and W antigens may protect this organism
from surface-associated or intracellular inactivation by macrophages.
4“Regardless of treatment before addition to cultured cells, VW inocula
survived and grew. It is assumed that growth may have occurred within
macrophages when IMS was present in the system, since phagocytosis
of the inoculum occurred soon after infection.
+Survival of the VW inoculum in this system gains greater significance
when contrasted with the fate of the TSM. Macrophages phagocytosed and
inactivated the TSM and VW organisms with nearly equal effectiveness.
Inactivation of both organisms was greatly enhanced when inocula were
incubated in IMS before addition to cell cultures. Survival of IMS-treated 
4* —
VW , VW and TSM organisms are compared in Fig, 5.
Scanning Electron Microscopy
Scanning electron microscopy (SEM) was used to verify the location 
of bacteria within cultured macrophages and to observe the phagocytosis 
process. Photomicrographs taken as different inocula interacted with 
cultured macrophages reveal that the VW organisms suspended in PBS or NMS 
were associated with cells during the early stages of infection (Fig. 6).
Table 2. ^  vitro interaction between Y. enterocolitica strain WA (VW , VW or TSM) and mouse
peritoneal phagocytic cells.
% Viable % Viable
Cell--assoc. bact. Medium-•assoc. bact. % Killing
Inoculum Time (min) PBS NMS IMS PBS NMS IMS PBS NMS IMS
+VW 5 3 . 8 8 . 7 21 . 4 94. 1 87 . 2 76. 4 2. 1 4 . 1 2 . 2
10 2 . 6 6 . 2 46 . 0 96, 1 88 . 8 50 . 9 1. 3 5 . 0 3*1
15 6.1 11, 5 65. 3 91. 1 85 . 3 33. 1 2 . 8 3 . 2 1 . 6
30 2 . 0 12. 3 84 . 5 96. 4 85. 1 14. 0 1. 6 2 . 6 1. 5
45 5. 7 10. 1 79.7 92 . 3 88 . 2 17. 3 2 . 0 1.7 3 . 0
60 3 . 4 7 . 5 90 . 0 93 . 5 91. 2 8 . 7 3 . 1 1 . 3 1. 3
vw" 5 4 . 7 4 . 4 5. 7 90 . 0 87 . 6 8 3 . 0 5 . 3 8 . 0 11. 3
10 5 . 0 2 . 5 4 . 1 82 . 9 80 . 6 74. 8 12.1 16. 9 21. 1
15 6 . 6 3 . 0 3. 1 83 . 4 75 . 8 57 . 2 10. 0 21 . 2 39 . 7
30 4 . 8 5 . 0 4 . 6 69 . 0 59. 4 41 . 4 26. 2 35 . 6 54 . 0
45 3. 9 4 . 4 2. 6 59 . 4 47 . 9 29 . 3 36. 7 47. 7 68. 1
60 4 . 2 3 . 2 3 . 6 42 . 3 38 . 8 12. 6 53 . 5 58 . 0 83 . 8
TSM 5 4 . 0 2 . 3 9 . 9 93 . 0 83 . 6 80 . 0 3 . 0 14.1 10.1
10 9 . 5 4 . 0 7 . 0 78.1 75 . 2 67. 4 12. 4 20 . 8 25 . 6
15 7 . 2 3 . 6 8 . 5 68. 7 66. 8 49 . 5 24. 1 29 . 6 4 2 . 0
30 8. 1 6 . 0 6 . 3 61. 3 55. 8 25.7 30 . 6 38 . 2 68 . 0
45 6. 0 8 . 1 2 . 6 48 . 8 44 . 0 15. 0 45 . 2 47 . 9 82 . 4
60 7. 8 7 . 0 4 . 0 32 . 0 28. 0 4 . 2 60 . 4 65 . 0 91 . 8
w
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Fig 5. Survival of Y. enterocolitica strain WA (VW , VW and TSM) 
in cultures of mouse peritoneal macrophages after treatment of inocula 
with immune mouse serum, VW -IMS ' W  ; VW -IMS ;wi 
TSM-IMS
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Fig. 6. Y. enterocolitica strain WA (TSM) in PBS being phagocytosed 
by cultured mouse peritoneal macrophages 5 minutes after 
infection. Note folds of plasme membrane engulfing inoculum 
(double arrows); one bacterium is partially ingested (single 
arrow), X 30,000.
Fig. 7. Y. enterocolitica strain WA (VW ) in IMS being phagocytosed 
en masse by cultured mouse peritoneal macrophages 5 minutes 
after infection. Plasma membrane is apparently folding over 
the inoculum to engulf it entirely. Opsonized extracellular 
organisms are clearly evident. X 13,000.
i
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Fig. 8, Cultured mouse peritoneal macrophages 60 minutes after
infection with enterocolitica strain WA (VW ) in PBS. 
Bacteria are rarely associated with plasma membranes of 
cells, and phagocytosis is not evident. X 20,000.
Fig. 9. Cultured mouse peritoneal macrophages 5 minute^ after 
infection with Y. enterocolitica strain WA (VW ) in IMS.
The inoculum is readily phagocyosed by the cells. Note 
folds of plasma membrane engulfing bacteria (double 
arrows); another bacterium is visible within the macrophage 
(single arrow). X 28,500.
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The TSM displayed similar affinity far the monolayers. In both instances, 
association with cells was accelerated when IMS was added to the system 
(Fig. 7).
+
The VW organisms interacted with cultured macrophages only by chance 
if the bacteria were pretreated with NMS or PBS, When contact occurred, 
macrophages did not phagocytose the bacteria (Fig. 8). Addition of IMS 
to the inoculum greatly enhanced attachment of bacteria to the plasma 
membranes of the cells, and effected ingestion (Fig. 9).
Transmission Electron Microscopy
Transmission electron micrographs of mouse peritoneal macrophages
infected with Y, enterocolitica in vitro revealed that neither IMS-coated 
+ —VW nor VW organisms influenced post-phagocytic events. Organisms of
both types remained membrane bound throughout the experiment (Figs. 10,
11). Apparent phagosome-lysosome formation was observed. The area
between the phagosome membrane and the organism became electron-dense as
lysosomes fused with the phagosomes (Fig. 14). Avirulent bacteria did
not undergo ultrastructural changes after fusion occurred (Figs. 11,14).
+
At no time were VW organisms free in the cytoplasms of infected macro­
phages, nor was there any sign that the bacteria inhibited fusion of the 
phagocytic vacuole with lysosomes.
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Fig. 10. Antibody-coated Y. enterocolitica strain WA (VW ) 
within phagocytic vacuoles of normal mouse peritoneal macro­
phages 5 minutes after infection. Note intact vacuole 
membranes. X 9,500.
Fig. 11, Antibody-coated Y_. enterocolitica strain WA (TSM) 
within cultured mouse peritoneal macrophages 5 minutes after 
infection. Note that cells are within intact phagosomes.
X 37,650.
Fig. 12. Antibody-coated ][. enterocolitica strain WA (VW ) 
within phagolysosomes 60 minutes after infection. Fusion 
of the phagosome with lysosomes has caused the intraphagosomal 
space to become electron-dense (A). Note the lack of change 
in bacterial ultrastructure. X 44,700.
Fig. 13. Antibody-coated Y. enterocolitica strain WA (VW ) 
within normal mouse peritoneal macrophages 60 minutes after 
infection. No ultrastructural changes in the ingested organism 
have occurred, X 52,370.
Fig. 14. Antibody-coated _Y. enterocolitica strain WA (TSM) 
within normal mouse peritoneal macrophages 5 minutes after 
infection. Note fusion of lysosomal granules with phagosomes 
(A) and granular appearance of the intraphagosomal space.
X 39,500.

41
■4* —In vivo Association of Y. enterocolltlca strain WA (VW or VW ) 
with Mouse Peritoneal Cells
Taplits and Myrvik (121) have described a method by which facultative 
intracellular parasitism can be indirectly ascertained. Organisms are 
suspended in PBS and injected into the peritoneal cavity of a mouse or 
other animal model. Within 1 hour, facultative intracellular organisms are 
associated with resident mononuclear phagocytes of the peritoneum. This 
association is quantified by crude separation of all peritoneal cells 
from extracellular bacteria found in lavage fluid of infected peritoneal 
cavities. This method lacks sensitivity but is a suitable presumptive 
test of facultative intracellular parasitism.
+
Data from this experiment (Table 3) indicate that the VW organism
interacts very little with peritoneal cells of the mouse except when the
inoculum is suspended in IMS, The VW organism and Listeria monocytogenes,
a known facultative intracellular pathogen, associate readily with
cellular portions of the aspirates, suggesting that V and W antigens may
play an important role in resistance of the organism to phagocytosis.
+Addition of IMS to VW inocula apparently increases association with 
cells because of the presence of antibodies which may interfere with
V and W antigen function or simply serve as opsonins.
Liver Perfusion Assay
+ —The interaction between enterocolitica strain WA (VW or VW ) and 
an isolated organ of the RES was studied by perfusion of livers of mice
with the organisms. Kupffer cells were not activated before livers were
used, because the effect of antibody on macrophage-mediated bactericidal 
activity in the absence of a cell-mediated immune response was being
Table 3. vivo interaction between enterocolitica strain WA
(VW^ and VW ) and mouse peritoneal cells.^
% Total Bacteria Recovered
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Challenge Organism Suspension Cell Assoc. Supernatant
VW PBS
NMS
IMS^
6.0
15.0
93.0
94.0
85.0 
7.0
VW PBS
NMS
IMgb
83.0
79.0 
92.6
17.0
21.0 
7.4
L. monocytogenes PBS
NMS
IMS
95.0
98.0
99.0
5.0
2.0 
1.0
a 6
mice were injected ip with 10 CPU of one of the organisms. One 
hour after injection, peritoneal cavities were lavaged and fractions 
were separated by centrifugation.
incubated for 1 hour at 37 C before injection into mice
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studied. Silica-treated livers served as mntrols for liver trapping 
capability in the absence of functional Kupffer cells.
The results (Table 4) parallel those of the in vitro studies. The 
VW^ inoculum suspended in PBS or NMS was apparently not removed from per­
fusion medium by phagocytic cells but was merely trapped. Organisms
coated with antibody were rapidly removed, and effluent fluids contained
4-few organisms. Unopsonized VW organisms apparently evaded association 
with Kupffer cells. Silica-treated livers consistently trapped approxi­
mately 38% of bacteria regardless of phenotype, which indicates that the 
liver can still function as a filter of blood in the absence of functional 
phagocytic cells. The results also indicate that organisms were killed
within perfused livers in the absence of IMS. However, IMS-treated cells 
were killed earlier in the perfusion process. This was probably due to 
increased phagocytosis of treated organisms, as revealed by a comparison 
of bactericidal activity of normal and control livers.
In vivo Studies : Passive Transfer of Sera
Carter e^ al. (29) reported that antibodies produced against heat-
treated enterocolit ica strain WA protected mice against iv challenge,
and that recipients of hyperimmune serum displayed similar immunity. It 
has been learned that the organism used in this study retained genes for 
V and W antigen production but was not cultivated for their expression. 
Hence, organisms used for immunization and challenge lacked essential viru­
lence antigens. This series of experiments was repeated using the VW 
organism for antibody production and the VW organism for challenge of 
treated animals.
T —Table 4, Survival of Y. enterocolltlca strain WA (VW and VW ) within perfused mouse liver.
a
% Viable 
trapped bacteria 
Inoculum Suspension Normal Control
VW PBS
NMS
IMS
24.5^
3 4 . 0
9 0 . 6
31 . 0
23 . 5
3 7 . 8
% Viable bacteria 
In effluent fluid
Normal
74 . 3
62 . 6
7 . 2
Control
67 . 5
70 . 8
60 . 2
% Inoculum Killed
Normal
1. 2
3 . 4
2.2
Control
1. 5
5 . 7
2.0
VW PBS
NMS
IMS
7 . 0
10. 7
1 . 5
3 8 . 0
24 . 3
30 . 6
23. 7
13. 3
6.0
57 . 0
72 . 3
67 . 4
69 . 3
76 . 0
92 . 5
5 . 0  
3 . 4
2.0
livers perfused with 10 CPU over a 1 hour period.
livers from silica-treated mice.
average of 10 liver perfusions
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Antibodies produced against the VW organism protected recipients
against challenge, but were ineffective against the VW^ inoculum
(Table 5). This could mean that the VW organisms did not have
enough time to elaborate their virulence antigens if IMS was present.
Contact with phagocytic cells could have occurred so rapidly that the
opsonized organisms were destroyed before a shift to full virulence
occurred. This is clearly evident from a comparison of protection
conferred by IMS against the two challenge organisms. The recipients of
VW^ Y. enterocolitica strain WA displayed an increase of 0.33 log,„— ----------------  1Ü
protection, which is insignificant when compared to the 3.39 log^^ 
protection shown by recipients of the VW organism. It is unknown
why both variants of this organism have similar values. Perhaps
—  + the VW organism suspended in PBS converts so rapidly to a VW phenotype
after iv injection that it causes similar pathology to occur.
The fate of VW and VW organisms in vivo after opsonization with
IMS was also examined. Opsonized organisms of either phenotype were
quickly removed from the bloodstream by the liver and spleen as was
expected. Either inoculum suspended in PBS was also sequestered by the
RES, however, a significantly greater quantity of the VW inoculum
remained free in the blood after 60 min.. This was apparently due to
antiphagocytic activity of the V and W antigens, but could have been
due to other surface-associated structures which remain undescribed.
Opsonized organisms which were trapped in livers and spleens were
—  + rapidly inactivated if VW but survived if VW -. Since inocula were
treated with prozone concentrations of IMS before injection into animals,
it was unlikely that clumps of bacteria were merely trapped
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Table 5. Protective effect of immune serum against intravenous 
challenge with Y. enterocolitica strain WA (VW^ or VW")
+VW VW"
Inoculum (CPU) PBS NMS IMS PBS NMS IMS
10^ 0/5^ 0/5 0/5 0/5 0/5 0/5
10^ 3/5 0/5 2/5 2/5 2/5 0/5
10^ 5/5 3/5 4/5 2/5 4/5 0/5
10^ 5/5 5/5 5/5 5/5 4/5 0/5
lo" 5/5 4/5 5/5 5/5 5/5 1/5
10® 5/5 5/5 5/5 5/5 5/5 3/5
^“50 =
102.16 1q 2.33 102.49 j q 2.29 1o 2.53 1q 5.68
Logs^g protection 0.0 0.17 0.33 0.0 0.24 3.39
^mice were challenged 1 hr. after iv injection of 1 ml of immune mouse 
serum (heat inactivated), titer = 1/512.
^deaths per group of 5 mice challenged, recorded for 14 days.
47
1x10^
t
76
5
4
3
2
o
O
O
cû
<
ex
LU
I—U<co
c û<>
IxltfI
l
5
4
3
1x10
98
7
6
5
4
3
IxlO'^
#
Blood :
VW^-PBS o — — O
VW -IMS o — — o
VW_-PBS A — — A
VW -IMS A — —  A
Llver and Spleen:
VW.^-PBS 
VW_-IMS 
VW_-PBS 
VW -IMS
1x10
l
1
5
4
3
2
1x10I6
5
4
3
1x10"
98
76
5
4
3
<>CP
OD>O— I m  2  >
<m
>
en-o
1x10
0 5 10 15 20 25 30 35 40 45 50 55 60
TIME (MINUTES)
Fig. 15 . Survival of enterocolitica strain WA (VW^ and VW”) in blood, 
livers and spleens of passively immunized and control mice after intra-
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■f"In the sinuses of these organs. The IMS-treated VW inoculum
was examined microscopically before injection for clumping of
organisms, and was found free of them. Phagocytosis of bacteria
by Kupffer cells was, therefore, the probable mechanism by which 
+opsonized VW inocula were filtered from the blood. Survival of 
these organisms in organs of the RES thus meant that V and W antigens 
aided the organism in resistance to cell-associated (presumed intra­
cellular) killing by macrophages.
Chapter IV 
DISCUSSION
Results of this study indicate that 1̂ , enterocolitica strain WA 
elaborates surface-associated virulence antigens, classical facultative 
intracellular parasitism does not occur. This was first indicated by 
extracellular localization of VW"*” bacteria in exudates from infected 
peritoneal cavities of outbred mice. After opsonization with antibodies 
against avirulent cells, fully virulent inocula became part of the cellular 
fraction. Although this method was originally used for study of facultative 
intracellular parasitism, several factors render it unsuitable for this 
purpose; a) interaction of pathogens with specific peritoneal cells cannot 
be described b) eventual dissemination of organisms t the liver and spleen 
alters the pathogen:peritoneal cell ratio c) PMNs enter the infected 
peritoneum and change the normal profile of the resident cell population.
After one hour, the latter two factors become evident, and therefore impose 
a time limit on the usefullness of this method. Despite these technical 
problems, it was determined that V and W antigens of this organism mediate 
antiphagocytic activity. Antibody neutralizes these functions, making 
association of this organism with peritoneal cells more likely.
Results of in vitro experiments provided further evidence that this 
organism is an extracellular pathogen. Bacteria without V and W antigens 
were readily ingested and destroyed by mouse peritoneal cells cultured in 
vitro, while VW"^ organisms remained in the culture medium. Virulent organisms 
pretreated with hyperimmune serum failed to resist phagocytosis, but were 
still viable and apparently multiplied within the cells. Observation of
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infected cultures with SEM revealed extensive intracellular association 
of IMS—treated VW organisms with mononuclear phagocytes, and also showed 
that removal of extracellular bacteria with PBS rinses was apparently 
effective. Therefore, viable counts of antibody-coated bacteria in cell 
cultures indicate that multiplication of organisms occurred within macro­
phages. It should be noted, however, that extracellular growth of organisms 
might still account for this observation since these bacteria could have 
been lost during the preparation procedure for SEM.
Measurement of macrophage bactericidal activity in the absence of 
bacterial growth was established by infecting cultures with an avirulent 
temperature-sensitive mutant, which survived without multiplication at 
the incubation temperature of the cell culture system. The TSM was 
ingested and killed by the macrophages. This occurred more rapidly when 
the bacteria were pretreated with IMS before infection of cultures. It 
was found that VW organisms were also ingested and destroyed, but that 
bacterial viability counts ran slightly higher than for the TSM. This 
difference may have been due to multiplication of VW bacteria outside 
of macrophages, indicating that removal of extracellular organisms with 
PBS rinses may not have been so effective.
There are many variables in an in vitro system of this type, and all 
could have altered the results from what would have occurred in vivo.
Many investigators have used a similar macrophage culture system, but few 
are aware of the pitfalls. Only 53% of cells from the peritoneal cavity 
can be classified as mononuclear phagocytes (32). Therefore, if cultures 
are used shortly after cells are collected, they are not "macrophage" 
cultures but "peritoneal cell" cultures. After 24 hours of incubation, 
lymphocytes and PMNs have usually died and the cultures attain some homogen­
eity. It must be remembered, however, that the remaining mononuclear
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phagocytes are not at the same stage of development. The phrase 
"macrophage culture" is an inexact term, but will be used here for 
want of a better one.
Another variable is the choice of the culture medium, especially 
the serum source and the quantity used. Media should have a minimal 
impact on cellular metabolism, particularly on secretory activity.
Usually, a medium such as Eagle's MEM is used. However, investigators 
differ on the choice of serum and the concentration, Wu et al. (137) 
and Cohn et al. (36) have shown that these variables are extremely 
important, since some sera, especially rabbit and guinea pig, are toxic 
for mouse macrophages, and high concentrations of other heterologous sera 
will enhance cell metabolism. Fetal calf serum, a choice of many, 
significantly enhances activity of mouse macrophages, while horse serum 
has minimal side effects. Changes in metabolism induced by heterologous 
sera are measured in relation to cell activity when mouse serum is used. 
Since mouse serum is so expensive and difficult to collect in sufficient 
quantity, horse serum was substituted. The 4% concentration used has 
been shown to have minimal effect on macrophage metabolic activity (37).
The method used for release of organisms from within macrophages is 
of prime importance because it cannot be so harsh that it destroys 
weakened, yet, viable, released organisms. Viability counts are the basis 
for killing curves, and poor methodology can have great impact on inter­
pretation of the data. Some published methods include: scraping cells 
off of surfaces and smearing them onto agar, smearing coverslips directly 
onto agar surfaces, sonicating cells, treating cells with distilled water, 
and exposing cells to iron filings and then a magnetic field, breaking 
them open. These techniques are, at best, crude. Except for sonication.
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none of these methods causes release of membrane-bound organisms, for 
example, pathogens within phagosomes or phagolysosomes. Sonication, 
like some of the others, damages partially degraded organisms which 
are still viable, and which would affect the viable cell count for a 
killing curve determination (133).
Hsu et al. (64) described a method which allows release of these
organisms and prevents their destruction afterward; removal from cell debris 
is also achieved. Sodium deoxycholate, a lilpid detergent, degraded macro­
phages within 5 minutes at room temperature when applied as a 0.5% saline 
solution. Its effect upon typhimurium after phagocytosis by macrophages 
was minimal, however, its activity against enterocolitica under similar
conditions was not studied. Therefore, use of this technique may have
+  —altered the results. The VW , VW and TSM organisms were resistant to this 
agent before they were added to cell cultures (data not shown) ; if SDOC 
killed partially degraded organisms, all inocula would have been more 
resistant to this action after intracellular interaction with macrophages.
Wilder et a l . (134) showed that addition of antibiotics to macrophage
cultures affected intracellular survival of monocytogenes. Mackaness 
(84) also noted this problem. Several researchers have reported that 
streptomycin and penicillin in particular are concentrated within lyso- 
somes (14,88^116). These antibiotics were used in this study during the 
early stages of cell culture, but were omitted at least 18 hours before 
cultures were used in experiments. Cells were given fresh antibiotic-free 
medium every 3 hours, and were repeatedly rinsed with warm PBS beforehand. 
This minimized drug retention by cells, since they are known to expel 
lysosomal contents in culture (35).
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Intracellular antibiotic concentration was not measured, therefore, 
it must be assumed that the drugs could have had an effect. If they 
did, the TSM served as a control for streptomycin activity, since peni­
cillin affects only growing cells. VW cells were controls for activity
+of both antibiotics. Growth of VW bacteria in cultures becomes more 
significant, because this variant was as susceptible to these compounds 
in vitro as the other inocula. However, virulence antigens may have made 
the VW^ organism relatively more resistant within cells.
//^ssessment o£ macrophage phagocytic activity by SEM proved much 
more convenient and accurate than the more popular fluorescent antibody 
technique. Specific reagents were not needed, background fluorescence 
was eliminated and cells were not destroyed during the process for 
staining of intracellular organisms, which might still have been protected 
from labelled antibody. It is surprising that SEM is not used more often 
for such studies.
This in vitro experiment provided indirect evidence that Y, entero- 
fcolitica strain WA multiplies within macrophages when V and W antigens 
are present. This is in conflict with results of Straley et al. (118) 
who showed that the organism elaborates the antigens within HeLa cells but 
does not grow. However, in this study the virulence antigens are elabor^ 
ated before phagocytosis occurs, so growth may be possible. Also, 
intracellular growth may halt after one hour of infection, but this 
is unlikely becuse cultures were destroyed when bacteria remained in 
them for extended time periods (data not shown). This would not have 
happened unless the bacteria produced a toxic product while not growing, 
however, no toxic effect of bacteria on cells was observed over one hour.
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Antibodies produced against surface antigens of the VW organism 
displayed only opsonic activity when IMS-treated VW"*” bacteria were phago- 
cytosed by cultured macrophages. Bacteria were not rendered as susceptible 
to intracellular killing as VW organisms. Resistance to these bactericidal 
mechanisms was probably due to V and W antigens, but could also have been 
due to antibody. Some workers have stated that the added layer of protein 
on opsonized bacteria provides additional protection against these mechan— i 
isms (38,44,54). However, Elsbach e^ a % . (47) have demonstrated that com­
ponents of immune serum may in fact increase net degradation of lipids in 
the outer membrane of enterotoxigenic coli. It is important to note 
that alteration of cell ultrastructure that is initiated by immune serum 
before ingestion cannot be easily distinguished from antibody-assisted 
mediation of an organism's destruction within phagolysosomes.
Of particular interest is the question of the effect that anti-V 
and anti-W antibodies have on fully virulent cells within macrophages.
P. B. Carter and R. R, Brubaker are presently attempting to produce mono­
clonal antibodies to the antigens for this reason, but have had limited 
success. Apparently, isolation of purified V and W antigens is complicated 
by their separation into subfractions, thus making hybridoma production 
Impossible (P. B. Carter, personal communication). Because of this problem, 
production of these antisera was not attempted in this study.
Much was learned from studies of this experimental system, but several 
facts must be considered. Peritoneal macrophages differ from others which 
function similarly during the host immune response to facultative intra­
cellular infections, Kupffer cells of the liver in particular (103). Also, 
peritoneal cells are mobile, and exhibit altered physiologic activity when 
attached to a surface (73). Lastly, it has been reported that without 
eliciting agents, peritoneal macrophages undergo changes in metabolism
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after they are removed from animals; even the heparin used to prevent 
them from clumping together has an adverse, yet reversible, effect(130). 
Thus, an in vitro study of the interaction of Kupffer cells with VW 
Y. enterocolitica strain WA was performed, but since these cells are 
difficult to isolate from livers, a liver perfusion model was used (95). 
This model, first described by Manwaring and Coe (89), has been used to 
study the interaction of the liver with Candida albicans. Staphylococcus 
aureus. Salmonella typhimurium, S. enteritidis and Streptococcus pneumoniae
(51,113,131). In these studies, specific immune serum had opsonic activity 
but did not render organisms more susceptible to destruction. However, 
Bonventr and Oxraan (13) reported that S. enteritidis and S. typhimurium 
were more susceptible to intracellular killing by Kupffer cells because 
bacterial multiplication was arrested when immune serum was added to the 
system.
In this study, VW organisms were trapped within livers and destroyed
when IMS was absent; bactericidal activity was enhanced when inocula
were pretreated with IMS. This indicated that the antibodies apparently 
had no effect on liver function, and simply enabled RES cells of the organ 
to inactivate increased numbers of organisms in less time. In contrast,
VW organisms apparently evaded phagocytosis when opsonins were absent, 
as demonstrated by similar viable cell counts of normal and silica-treated 
control organs. IMS facilitated adherence of these organisms to Kupffer 
cells and thus triggered the ingestion process. Once again, however, 
fully virulent bacteria survived, probably within RES cells. This is
assumed to occur, since silica is a common agent used for destruction of
Kupffer cells and has no effect on liver architecture or on other hepatic 
cell types (51).
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The liver prefusion technique is not without shortcomings. The 
perfusions must be preformed at room temperature instead of the body 
temperature of the mouse. Livers must be kept moist during the pro­
cedure. When the system is set up, the organs must be rinsed quickly 
with PBS before blood clotting occurs, and connections must be water­
tight. Fluid pressure must remain steady during the procedure, and 
must be low enough to prevent swelling of the liver, which indicates 
damage to the sinusoids. Alteration of the liver's structure during 
perfusion is impossible to avoid. Some swelling and distortion occurs, 
and severe damage to the lobes nearest the hepatic portal vein is com­
mon despite great caution. The end result is that some organisms are 
lost during the process, typically about 5% of an inoculum.
Another problem with this method is that nonspecific adherence of 
antibody-coated bacteria to reticular cells of sinusoids might occur.
This variable cannot be accurately measured, and makes assessment of 
Kupffer cell function difficult. However, since silica is toxic for 
macrophages only, the indirect determination used in this project is 
adequate because attachment of bacteria to sinusoid walls is considered 
a function of the liver's trapping capacity.
When Carter et a l . (29) described a protective humoral immune res­
ponse to systemic yersiniosis, the challenge organism was cultivated 
under conditions which prohibited elaboration of V and W antigens. There­
fore, the challenge was not made with fully virulent organisms. In this 
study, antibodies produced against avirulent (VW ) enterocolitica 
strain WA did not protect recipients against challenge with VW~*̂  organisms. 
Antibodies were opsonic, but did not influence destruction of sequestered 
organisms in livers and spleens of challenged animals. Studies revealed that
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opsonized VW bacteria were rapidly sequestered and destroyed within RES 
+organs, but VW organisms remained viable and multiplied. This indicated
that the V and W antigens had antiphagocytic activity and, perhaps, helped
the organism avoid destruction by the RES.
In the long-term protection experiment, LD^q values for control 
+  -suspensions of VW and VW bacteria were similar. This did not seem
+correct because VW organisms were supposedly more virulent in mice.
However, this similarity would be possible if a transformation of
VW organisms to the VW phenotype occurred after they were injected
into animals. Some results presented in this work, combined with those
of other investigators, provide support for this hypothesis.
At the time that Carter et al.(29) reported that immune serum
was protective against challenge with this organism, its ability to
produce V and W antigens was unknown. Control infections of mice with
Y. entereditica strain WA suspended in PBS resulted in death of animals,
even though the short-term interaction between the organism and the RES
resulted in destruction of bacteria. However, long-term in vivo studies
revealed that after an initial phase of inactivation, organisms multiplied
— +
within livers and spleens. Transformation from VW to VW may have 
occurred after the bacteria were sequestered in the liver and spleen.
This process may also occur in the bloodstream of infected animals. 
Higuchi et al (35) reported that V and W antigens are produced under 
conditions found in serum. Also, Straley et al .(118) showed that 
this strain of Y. enterocolitica could produce these antigens in serum, 
and that they are produced maximally within cells. The latter characteristic 
has been demonstrated for pestis CIS). This suggests that if
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the organism can accomplish the shift to virulence soon enough after 
ingestion by macrophages, its survival is ensured and it is technically 
a facultative intracellular parasite. However, it apparently does 
not remain so, since abscessess, not granulomas, form in infected RES 
organs, indicating an extracellular mode of multiplication for the 
organism. This is true for humans and experimental mouse models alike.
Before vivo studies were performed, partial assessment was made 
of the effect of complement on Y. enterocolitica strain WA. It was 
found that this organism resists complement-mediated bacteriolysis by 
the classical and properdin pathways. Activation of either pathway was 
not determined. Therefore, complement activation without bacteriolysis 
may be involved in intracellular destruction of this organism in vivo, 
as it has been shown for other bacteria which undergo similar 
interaction with this mechanism (47). Further, this finding provided 
indirect evidence that this organism is a possible extracellular pathogen.
The V and W virulence antigens of this organism do not effect 
alteration of post-ingestion processes within normal mouse peritoneal 
macrophages. Fusion of phagosomes with lysosomes apparently occurs, yet 
virulent organisms survive and multiply, while avirulent bacteria are 
inactivated. Neither cell type undergoes ultrastructural changes assoc­
iated with lysis.
Leake et al. (80) have described phagolysosome formation within
macrophages which were not treated with a lysosome-specific reagent 
prior to experimental infection with typhimurium. Fusion of these 
structures with phagosomes was determined by the appearance of granular 
material around membrane-bound bacteria. Also, the fusion process was 
observed; small, electron-dense granules were seen emptying their contents 
into the phagosomes, creating the dense region around the bacteria.
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In this study, similar observations were noted. Phagosomes 
were seen fusing with lysosomes, and many vacuoles containing bacteria 
were filled with electron-dense material within 10 min after organisms 
had been added to the cell cultures. No changes in bacterial ultra­
structure were noted. This is characteristic of other Gram-negative 
organisms which have been studied (47).
Of particular importance is the fact that some of the cells pre­
pared for electron microscopy showed evidence of dehydration artifact; 
some membrane-bound structures were swollen and a small proportion of the 
cells had been lysed. However, intracellular bacteria were still membrane- 
bound, structures bearing a strong resemblance to lysosomes were still 
seen fusing with phagosomes and the electron-dense material within these 
structures was consistently noted regardless of the general condition of 
the macrophages. Therefore the evidence presented herein constitutes 
valid evidence that VW . enterocolitica strain WA does not display 
unusual characteristics within macrophages in vitro.
Findings of this study suggest that this strain of Ŷ . enterocolitica 
is not a facultative intracellular pathogen when fully virulent. Also, 
antibody is of little value for host resistance to infection, except for 
enhancement of phagocytosis. In the absence of an activated RES, phagocy- 
tosed organisms with V and W antigens resist intracellular killing by these 
cells and multiply within them. The antigens also have antiphagocytic 
activity, which is neutralized by antibodies formed against other components 
of the outer surface of the organism.
Chapter V 
SUMMARY
Results of this study provide evidence that Y. enterocolitica
strain WA is not a facultative intracellular organism in mice when V and W
virulence antigens are elaborated on the outer surface of the cell wall.
Intracellular association with mononuclear phagocytes occurred only
after the fully virulent organism was treated with immune serum. Survival
+of the IMS-treated VW organism within RES cells indicated that these 
antigens confer resistance to macrophage-mediated bactericidal mech­
anisms, and that antibodies produced against other surface components 
have opsonic activity only, and are not protective against systemic 
challenge infection.
Recent reports of other investigators, taken with these findings, 
indicate that this strain of Y. enterocolitica may establish systemic
infection after the enteric syndrome by undergoing a transformation from 
—  4-a VW to a VW phenotype before entry into the bloodstream, or shortly 
afterward. Organisms with the capability to produce the V and W antigens 
elaborate these structures maximally after ingestion by macrophages, and 
grow within these cells when fully virulent. A critical time period 
exists between the appearance of these antigens on the outer surface of 
the organisms and their contact with lysosomal contents after ingestion.
If the organism is fully virulent before phagosome-lysosome fusion occurs, 
it survives and grows ; the macrophage dies, and the organism becomes 
an extracellular pathogen. If V and W antigens are not produced when 
ingestion occurs, the organisms die within the phagocytes. The absence of 
an early humoral immune response during systemic yersiniosis ensures that
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organisms will probably not be rapidly opsonized by serum components 
and ingested by the RES cells, thus allowing the shift to full virulence 
with resultant extracellular multiplication and abscess formation in 
RES organs.
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APPENDIX
Media Formulations
A. Luria Broth
Bacto Tryptone ..............  10.0 gm
Bacto Yeast Extract .........  5.0 gm
NaCl .....................   0.5 gm
Distilled Water .............  1000 ml
If agar medium is desired, add 15.0 gm Bacto Agar per liter 
Autoclave at 15 lbs. pressure (121°C) for 15 min. .
B. Higuchi*s Medium
Stock Solutions :
Solution 1 : Amino Acid Stock
1-glutamate  12.0 gm
1-phenylalanine  0.4 gm
1-methionine..................  0.24 gm
1-valine  0.8 gm
1-leucine.....................   0.2 gm
1-lysine  0.2 gm
1-proline  0.8 gm
1-threonine.................... 0.16 gm
1-tyrosine ..........0.2 gm
1-arginine...........0.2 gm
1-isoleucine........ 0.5 gm
1-cysteine.......... 0.157 gm
1-tryptophan........0.02 gm
1-alanine 0.4 gm
glycine.............. 2.0 gm
Dissolve individually in 100 ml distilled water before addition to 
remaining amino acids; bring total volume to 500 ml with distilled 
water.
Solution 2 : Vitamin Stock
Biotin .............0.002 gm
Thiamine HCl ......0.005 gm
Calcium pantothenate ....0.005 gm
Dissolve in 100 ml distilled 
water.
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Solution 3 : Salts Stock
K^HPO^ ...........  0.435 gm
Sodium Citrate ... 2.94 gm
Sodium Gluconate
NH^Cl
FeSO^ * 7 H^O ..
M n S O ^  • H ^ O
. 2.18 gm 
. 0.535 gm 
. 0.028 gm 
. 0.0016 gm
Dissolve in 100 ml distilled water.
Solution 6 : Magnesium chloride Stock
Dissolve 4.06 gm MgCl^ * 7 H 2 O in 50 ml distilled water.
Solution 7 : Calcium chloride Stock
Dissolve 0.44 gm CaCl 2 * H^O in 50 ml distilled water.
Combine amino acids, salts, vitamins and individual amino acid 
stock solutions; adjust pH = 7.2 with 1 N HCl or 1 N NaOH if needed 
Add MgCl^ and CaCl^, maintaining pH = 7.2 so precipitate does not 
form. Filter sterilize, store at 4°C.
Buffers
Phosphate Buffer ( pH = 7.0)
Stock Solutions:
A. 0.2 M solution of monobasic sodium phosphate (Dissolve 27.8 gm 
in 1000 ml distilled water.
B. 0.2 M solution of dibasic sodium phosphate (Dissolve 53.65 gm 
in 1000 ml distilled water).
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Phosphate Buffer (cont.)
For a pH = 7.0, add 39.0 ml of Solution A to 61.0 ml of 
Solution B and dilute to a total of 200 ml with distilled water. 
Autoclave at 15 lbs. pressure (l21^C) for 15 min.. If needed, 
akjust pH with 1 N HCl or 1 N NaOH before sterilization.
Citrate Buffer (pH = 5.5)
Stock Solutions
A. 0.1 M solution of citric acid (Dissolve 21,01 gm in 1000 ml 
of distilled water ).
B. 0.1 M solution of sodium citrate (Dissolve 29.41 gm in 1000 ml 
of distilled water ).
Add 16.0 ml of Solution A to 34.0 ml of Solution B, and dilute to
a total of 100 ml with distilled water. Adjust pH = 5.5 with 1 N HCl
or 1 N NaOH if needed. Autoclave at 15 lbs. pressure (121°C) for
15 min..
Millonig*s Buffer (pH = 7.2)
1. Dissolve 16.88 gm NaH^PO^ ' H^O in 747 ml of distilled water
2. Dissolve 3.86 gm NaOH in 153 ml distilled water.
3. Dissolve 5.4 gm glucose in 100 ml distilled water.
Combine solutions for a total of 1000 ml. Store at 4°C.
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Phosphate Buffered Saline (pH = 7.2)
Stock Solutions:
Phosphate Buffer Stock
1. Dissolve 18.88 gm Na^HPO^ in 1000 ml distilled water, for a 0.133 M 
solution. Adjust pH to 7.2 with 1 N NaOH or 1 N HCl.
Saline Stock
1. Dissolve 8.5 gm in 975 ml of distilled water; final solution is
0.85% (0.15 M ) , when diluted with phosphate buffer.
Combine 25 ml of phosphate buffer stock with 975 ml of saline 
stock for a total of 1000 ml. The pH should equal 7.2.
May - Grunwald Giemsa Stain
Gierosa Stock Solution
Giemsa Powder ..........1.0 gm
G l y c e r i n .............. 66.0 ml
Methyl Alcohol........ 66.0 ml
Mix glycerin and giemsa powder. Place in 60°C oven for 2 hours.
Add 66.0 ml methyl alcohol carefully, and mix.
Jenner Stock Solution
Jenner Stain, dry powder  1.0 gm
Hethvl Alcohol................  600.0 ml
Giemsa Solution (Working)
Add 1.2 to 1.5 ml Giemsa stock solution (50 drops) to 50.0 ml 
of distilled water.
Jenner Solution (Working)
Add 25.0 ml of Jenner stock solution to 25.0 ml of distilled water 
Prepare fresh each time stain procedure is performed.
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May-Grunwald Giemsa Stain (cont.)
Glacial Acetic Acid Solution (1%)
Add 1.0 ml of glacial acetic acid to 99.0 ml of distilled water. 
Do this in a fume hood for your protection.
Procedure :
1. Fix cells in absolute methyl alcohol for 6 minutes.
2. Stain in Jenner solution (working) for 6 minutes.
3. Stain in Giemsa solution (working) for 45 minutes.
4. Differentiate in 1% glacial acetic acid solution for 30 seconds
5. Rinse under running tap water.
6. Allow to air dry, and then examine under light microscope.
